We demonstrated that a set of five select AAs (SAA) can increase the expression levels and activities of CFTR, ANO1, and SLC26A9 using an in vitro HBEC culture model to study CF with Class I and Class II mutations. This evidence concerns the gene CFTR and cystic fibrosis.